These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24562856)

  • 1. Insights into the influence of 5-HT2c aminoacidic variants with the inhibitory action of serotonin inverse agonists and antagonists.
    Galeazzi R; Massaccesi L; Piva F; Principato G; Laudadio E
    J Mol Model; 2014 Mar; 20(3):2120. PubMed ID: 24562856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicted structures and dynamics for agonists and antagonists bound to serotonin 5-HT2B and 5-HT2C receptors.
    Kim SK; Li Y; Abrol R; Heo J; Goddard WA
    J Chem Inf Model; 2011 Feb; 51(2):420-33. PubMed ID: 21299232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Action of Cassiae Semen for Weight Management: A Computational Molecular Docking Study of Serotonin Receptor 5-HT2C.
    Yuen H; Hung A; Yang AWH; Lenon GB
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
    Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of human serotonin 2c G-protein-coupled receptor bound to agonists and antagonists.
    Bray JK; Goddard WA
    J Mol Graph Model; 2008 Aug; 27(1):66-81. PubMed ID: 18499489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development.
    Wold EA; Wild CT; Cunningham KA; Zhou J
    Curr Top Med Chem; 2019; 19(16):1381-1398. PubMed ID: 31288724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT
    Peng Y; McCorvy JD; Harpsøe K; Lansu K; Yuan S; Popov P; Qu L; Pu M; Che T; Nikolajsen LF; Huang XP; Wu Y; Shen L; Bjørn-Yoshimoto WE; Ding K; Wacker D; Han GW; Cheng J; Katritch V; Jensen AA; Hanson MA; Zhao S; Gloriam DE; Roth BL; Stevens RC; Liu ZJ
    Cell; 2018 Feb; 172(4):719-730.e14. PubMed ID: 29398112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
    Canal CE; Morgan D; Felsing D; Kondabolu K; Rowland NE; Robertson KL; Sakhuja R; Booth RG
    J Pharmacol Exp Ther; 2014 May; 349(2):310-8. PubMed ID: 24563531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore-directed homology modeling and molecular dynamics simulation of G protein-coupled receptor: study of possible binding modes of 5-HT2C receptor agonists.
    Zuo Z; Chen G; Luo X; Puah C; Zhu W; Chen K; Jiang H
    Acta Biochim Biophys Sin (Shanghai); 2007 Jun; 39(6):413-22. PubMed ID: 17558446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Basicity as a Characteristic for Atypical Ligands of Serotonin Receptor 5-HT2.
    Podlewska S; Bugno R; Lacivita E; Leopoldo M; Bojarski AJ; Handzlik J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into binding modes of 5-HT2c receptor antagonists with ligand-based and receptor-based methods.
    Lu C; Jin F; Li C; Li W; Liu G; Tang Y
    J Mol Model; 2011 Oct; 17(10):2513-23. PubMed ID: 21203788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity.
    Booth RG; Fang L; Huang Y; Wilczynski A; Sivendran S
    Eur J Pharmacol; 2009 Aug; 615(1-3):1-9. PubMed ID: 19397907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modelling of human 5-hydroxytryptamine receptor (5-HT2A) and virtual screening studies towards the identification of agonist and antagonist molecules.
    Gandhimathi A; Sowdhamini R
    J Biomol Struct Dyn; 2016 May; 34(5):952-70. PubMed ID: 26327576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational design of thermostabilizing point mutations for G protein-coupled receptors.
    Popov P; Peng Y; Shen L; Stevens RC; Cherezov V; Liu ZJ; Katritch V
    Elife; 2018 Jun; 7():. PubMed ID: 29927385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A short history of the 5-HT
    Palacios JM; Pazos A; Hoyer D
    Psychopharmacology (Berl); 2017 May; 234(9-10):1395-1418. PubMed ID: 28265714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants.
    Labasque M; Meffre J; Carrat G; Becamel C; Bockaert J; Marin P
    Mol Pharmacol; 2010 Nov; 78(5):818-26. PubMed ID: 20699324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug discovery targeting human 5-HT(2C) receptors: residues S3.36 and Y7.43 impact ligand-binding pocket structure via hydrogen bond formation.
    Canal CE; Cordova-Sintjago TC; Villa NY; Fang LJ; Booth RG
    Eur J Pharmacol; 2011 Dec; 673(1-3):1-12. PubMed ID: 22020288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and pharmacological evidence that 5-HT2C receptor activation, but not inhibition, affects motivation to feed under a progressive ratio schedule of reinforcement.
    Fletcher PJ; Sinyard J; Higgins GA
    Pharmacol Biochem Behav; 2010 Nov; 97(1):170-8. PubMed ID: 20624416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. We Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders.
    Cheng J; Kozikowski AP
    ChemMedChem; 2015 Dec; 10(12):1963-7. PubMed ID: 26507582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of serotonin agonists, neutral antagonists, and inverse agonists in pigeons: perspectives on intrinsic efficacy measurements in vivo.
    Farrell M; Rosenzweig-Lipson S; Walker E
    Psychopharmacology (Berl); 2010 Aug; 211(2):149-59. PubMed ID: 20526585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.